Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net income	$ 13,534,601	$ 22,928,102
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments	28,936	137,899
Other-than-temporary impairments	0	300,000
Realized investment gains, net	(10,143,014)	(12,723,566)
Change in fair value of equity securities	(10,838,322)	(22,050,489)
Amortization of cost of insurance acquired	581,930	604,549
Depreciation	868,630	814,202
Stock-based compensation	246,534	246,757
Charges for mortality and administration of universal life and annuity products	(4,839,551)	(4,948,332)
Interest credited to account balances	3,068,614	3,177,834
Change in accrued investment income	375,806	42,511
Change in reinsurance receivables	460,659	91,579
Change in policy liabilities and accruals	(2,458,575)	(2,613,125)
Change in income taxes receivable (payable)	78,738	2,221,052
Change in other assets and liabilities, net	3,749,194	9,987,926
Net cash used in operating activities	(5,285,820)	(1,783,101)
Proceeds from investments sold and matured:
Fixed maturities available for sale	8,563,966	54,220,638
Equity securities	10,219,197	843,260
Mortgage loans	4,824,430	4,496,554
Real estate	11,620,038	12,783,088
Notes receivable	4,296,998	2,559,264
Policy loans	1,324,183	1,423,014
Short-term investments	0	2,114,000
Total proceeds from investments sold and matured	40,848,812	78,439,818
Cost of investments acquired:
Fixed maturities available for sale	(11,655,148)	(42,955,401)
Equity securities	(1,323,310)	(9,538,853)
Trading securities	(132,518)	0
Mortgage loans	(4,216,644)	(16,453)
Real estate	(1,729,000)	(10,113,852)
Notes receivable	(8,532,796)	(4,000,000)
Policy loans	(973,594)	(1,244,976)
Short-term investments	0	(7,549,076)
Total cost of investments acquired	(28,563,010)	(75,418,611)
Net cash provided by investing activities	12,285,802	3,021,207
Cash flows from financing activities:
Policyholder contract deposits	3,542,562	3,548,809
Policyholder contract withdrawals	(3,578,980)	(2,849,310)
Purchase of treasury stock	(849,265)	(1,217,802)
Non controlling contributions (distributions) of consolidated subsidiary	(535,662)	(247,592)
Net cash used in financing activities	(1,421,345)	(765,895)
Net increase in cash and cash equivalents	5,578,637	472,211
Cash and cash equivalents at beginning of period	20,150,162	25,434,199
Cash and cash equivalents at end of period	$ 25,728,799	$ 25,906,410